论文部分内容阅读
AIM To examine the safety and efficacy of mesenchymal stem cell（MSC） therapy for intracerebral haemorrhage with neurological dysfunctions for a year.METHODS MSC were ex vivo expanded from 29 mL（17-42 mL） autologous bone marrow. Patients were randomized to